NovoCure (NVCR) Operating Income Growth (1y) (2015 - 2026)
NovoCure (NVCR) Operating Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.18% |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn | 73.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.27% |
| Mar 31, 2026 | -78.05% |
| Dec 31, 2025 | 36.19% |
| Sep 30, 2025 | -12.24% |
| Jun 30, 2025 | -17.69% |
| Mar 31, 2025 | 8.80% |
| Dec 31, 2024 | -22.41% |
| Sep 30, 2024 | 44.90% |
| Jun 30, 2024 | 46.41% |
| Mar 31, 2024 | 31.09% |
| Dec 31, 2023 | -20.33% |
| Sep 30, 2023 | -136.66% |
| Jun 30, 2023 | -196.57% |
| Mar 31, 2023 | -7,375.06% |
| Dec 31, 2022 | -83.68% |
| Sep 30, 2022 | -187.78% |
| Jun 30, 2022 | -71.84% |
| Mar 31, 2022 | -815.91% |
| Dec 31, 2021 | -293.50% |
| Sep 30, 2021 | -156.93% |